Please, Maria Chin, can we have some Ivermectin?

Posted on May 23, 2021


God’s peace be with you.

I last wrote to you on 27th April to ask, amongst other things, that you put the following questions to the minister of health :

Is the health ministry conducting clinical trials of ivermectin? If so, what stage are the trials at and when can a report on safety and efficacy of the same be made public? If no trials have commenced, why not?

In a telephone conversation on 19th May, you informed me that my questions had been forwarded to the minister but, to-date, you had not received a response.

Thank you.

On the day that I wrote you, it was reported by Astro Awani that there were a total of 2.733 new positive Covid-19 cases throughout the country, with 13 deaths.

Yesterday, Malaysiakini reported 6,320 new cases and 50 deaths.

In fact, yesterday was the fourth consecutive day that new positive cases exceeded 6,000.

You surely will agree that the situation is worsening.

In my earlier letter to you, I had mentioned that, in a webinar I hosted, one of the panel doctors “confirmed that clinical trials of the drug, ivermectin, were being conducted at the Sg Buloh Hospital, but he was not aware of the stage at which these trials had reached”, and that I had been later informed by a source that “the clinical trials by MOH were awaiting ethics approval”.

On 16th May, the MOH DG broke the silence.

Malaysiakini reports : In response to unproven claims regarding the use of Ivermectin as a preventive drug for Covid-19, the Health Ministry has announced plans to carry out randomised clinical trials to see if the drug can be used.

Malaysiakini quotes the DG : “The Health Ministry (MOH) Malaysia has initiated a randomised clinical trial to repurpose Ivermectin and evaluate its efficacy and safety in high-risk Covid-19 patients. The trial will enrol 500 Covid-19 patients admitted to 12 MOH hospitals. Through this study, MOH hopes to have a correct perspective on the clinical effectiveness of Ivermectin,”

I ask you to note 2 very important points here.

The report first speaks of unproven claims regarding the use of Ivermectin as a preventive drug, yet the clinical trial announced by the DG is to evaluate the efficacy of Ivermectin in high-risk Covid-19 patients.

A test to ascertain the efficacy of Ivermectin as a therapeutic, but not as a prophylactic!


The DG is also reported to have said, in respect of clinical trials conducted in other jurisdictions with Ivermectin, that these have been tests using, “such high doses of Ivermectin that is implausible in a living being”, “had limitations including small sample sizes, non-controlled study designs”, and producing results which were “circumstantial hype” and “inconclusive”.

And yet, on 5th May, our DG seemingly ignorant of this, CNN reported that the sixth hospital in the Philippines was given a compassionate special permit to administer Ivermectin on Covid-19 patients whilst, in Indonesia that very day, ministerial support was given for Emergency Use Authorisation (EUA) of Ivermectin. As the document related to this

acknowledges the efficacy of Ivermectin both as a prophylactic and a therapeutic, the proposed EUA may well be for both uses of this drug.

As a prohylactic, Maria. That means we do not wait for people to be infected before the drug is administered.

On 13th May, Reuters reported that the Indian states of Goa and Uttarakhand planned “to dose their populations with the anti-parasitic drug ivermectin to protect against severe COVID-19 infections”.

Again, to protect, Maria.

Last night, in a live stream, more than 200 of us listened to three highly respected doctors respectfully explain that the DG had got it wrong, and that a significant number of the randomised controlled trials (RCT) conducted with Ivermectin, whilst small in scale, had, upon systematic review and meta analysis, attained the gold standard of evidence-based medicine and offered compelling evidence of efficacy, certainly as a therapeutic, and possibly as a prophylactic.

As I write to you now, Malaysiakini has just reported that, as at 3.16pm, the number of new positive Covid-19 patients has hit an all-time high : 6796.

Maria, I will not trouble you to get a reply from the health minister. His DG has spoken.

As a matter of real urgency, though, please put the following to the DG :

  1. It is not enough to commence randomised clinical trials with Covid-19 patients. This would only aid evaluation of Ivermectin as a therapeutic. Conduct trials to ascertain its efficacy as a preventive. I am, since the last week of April, on an Ivermectin prophylactic protocol as prescribed by the Front Line Covod-19 Critical Care Alliance (FLCCC). Let me be the first to volunteer for such a trial.
  2. The trials must proceed without any delay and there must be full and frank disclosure of the results of the same to the public.
  3. Pending commencement and completion of the trials, secure Emergency Use Authorisation of Ivermectin for Covid-19 patients. For those uninfected who elect to use Ivermectin as a prophylactic, make it possible for them to do the same under medical supervision, and under prescription.
  4. To facilitate No. 3, above, without delay, take all steps necessary to facilitate mass importation, by the government, of Ivermectin. Its importation and distribution should not be placed in the hands of those who will see this as an opportunity for enrichment

In my earlier letter, I asked when you might hold a town hall meeting with us, the PJ voters?

Online, of course.